AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer

The lack of effective screening and successful treatment contributes to high ovarian cancer mortality, making it the second most common cause of gynecologic cancer death. Development of chemoresistance in up to 75% of patients is the cause of a poor treatment response and reduced survival. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardizzoia, Alessandra, Jemma, Andrea, Redaelli, Serena, Silva, Marco, Bentivegna, Angela, Lavitrano, Marialuisa, Conconi, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380391/
https://www.ncbi.nlm.nih.gov/pubmed/37511212
http://dx.doi.org/10.3390/ijms241411455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380391/
https://www.ncbi.nlm.nih.gov/pubmed/37511212
http://dx.doi.org/10.3390/ijms241411455

Ejemplares similares